Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TOPIRAMATE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for TOPIRAMATE EXTENDED-RELEASE CAPSULES. TOPIRAMATE extended-release capsules, for oral use Initial U.S. Approval: 1996
Medication labelWhy this: Advisory · dailymed-prescription
Topiramate extended-release capsules are indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older. Topiramate extended-release capsules are indicated as adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut Syndrome in patients 2 years of age and older. Topiramate extended-release capsules are indicated for the preventive treatment of migraine in patients 12 years of age and older.
- generic_name
- topiramate
- product_names
- topiramate
- ndc
- 72603-120, 72603-121, 72603-122, 72603-123, 72603-124, 72603-120-01, 72603-121-01, 72603-122-01, 72603-123-01, 72603-124-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en